Anemia. Iron deficiency anaemia
Conditions
Interventions
Intervention 1: Intervention group: Ferfolic pills containing 60 mg ferrous sulfat and 400 µg folic acid, Will be used in one group one pill every week and the other group, one pill in the first 4 day
Treatment - Drugs
Placebo
Intervention group: Ferfolic pills containing 60 mg ferrous sulfat and 400 µg folic acid, Will be used in one group one pill every week and the other group, one pill in the first 4 days of menstrual b
Control group: Placebo contains pharmacologically useless substances such as lactose, starch and Avisel (micro crystalin selulose), This materials are used for pharmacological and non pharmacological
Sponsors
Deputy of Research, Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
15 Years to 49 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Students living in dormitories of Tabriz university of medical sciences, Not using vitamin and iron complementary in the last 3 month, Not using oral or injection steroidal hormones, Not using IUD, Not existence of a hepatic, infectious or parasitic diseases in the time of study, Not existence of hematologic disorders such as thalassemia or hemophilia, any contraindication iron complementary, Not existence psychological disorders, Not existence systemic disorders which can affect menstrual bleeding such as diabetes, thyroid disorders, hyperadrenalism,… , participants with signs and symptoms of anemia which investigator finds in clinical examination( assessing color of mucosa, nails, conjunctive), participants with hemoglobin below 12g/dl. Exclusion criteria: Not being interested to continue (leaving study), diagnosis of other types of anemia during the study, diagnosis of systemic, infectious, parasitic or hepatic disorders during study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemoglobin level. Timepoint: Once before the intervention and second time 4 months after beginning the intervention. Method of measurement: Based on result laboratory by Cell counter device model H1.;Mood. Timepoint: Once before the intervention and second time 4 months after beginning the intervention. Method of measurement: Based on POMS SF questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Menstrual bleeding level. Timepoint: Once before the intervention and second time 4 months after beginning the intervention. Method of measurement: Based on Higham questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAyemeh Hassanpour seiah estalkhi
Tabriz University of Medical Sciences
Outcome results
None listed